Your browser doesn't support javascript.
loading
DPYD*7 as a Predictor of Severe Fluoropyrimidine-Related Adverse Events.
de With, Mirjam; Brufau, Gemma; van den Berg, Laila A; de Man, Femke M; Trajkovic, Marija; Thijs, Martine F; Castel, Rob; Vermeer, Henricus J; El Bouazzaoui, Samira; van Hemel, Amber; Matic, Maja; Mathijssen, Ron H J; Bins, Sander; van Schaik, Ron H N.
Afiliación
  • de With M; Department of Medical Oncology, Erasmus Medical Center Cancer Institute, Rotterdam, the Netherlands.
  • Brufau G; Department of Clinical Chemistry, Erasmus University Medical Center, Rotterdam, the Netherlands.
  • van den Berg LA; Department of Clinical Chemistry and Haematology, Albert Schweitzer Hospital, Dordrecht, the Netherlands.
  • de Man FM; Department of Medical Oncology, Erasmus Medical Center Cancer Institute, Rotterdam, the Netherlands.
  • Trajkovic M; Department of Medical Oncology, Erasmus Medical Center Cancer Institute, Rotterdam, the Netherlands.
  • Thijs MF; Department of Medical Oncology, Albert Schweitzer Hospital, Dordrecht, the Netherlands.
  • Castel R; Department of Medical Oncology, Ikazia Hospital, Rotterdam, the Netherlands.
  • Vermeer HJ; Department of Clinical Chemistry and Haematology, Albert Schweitzer Hospital, Dordrecht, the Netherlands.
  • El Bouazzaoui S; Medical Laboratory Ikazia, Ikazia Hospital, Rotterdam, the Netherlands.
  • van Hemel A; Department of Clinical Chemistry and Haematology, Albert Schweitzer Hospital, Dordrecht, the Netherlands.
  • Matic M; Department of Clinical Chemistry, Erasmus University Medical Center, Rotterdam, the Netherlands.
  • Mathijssen RHJ; Department of Clinical Chemistry, Erasmus University Medical Center, Rotterdam, the Netherlands.
  • Bins S; Department of Clinical Chemistry, Erasmus University Medical Center, Rotterdam, the Netherlands.
  • van Schaik RHN; Department of Medical Oncology, Erasmus Medical Center Cancer Institute, Rotterdam, the Netherlands.
JCO Precis Oncol ; 6: e2200180, 2022 07.
Article en En | MEDLINE | ID: mdl-35862869
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Dihidrouracilo Deshidrogenasa (NADP) / Fluorouracilo / Antimetabolitos Antineoplásicos Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: JCO Precis Oncol Año: 2022 Tipo del documento: Article País de afiliación: Países Bajos Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Dihidrouracilo Deshidrogenasa (NADP) / Fluorouracilo / Antimetabolitos Antineoplásicos Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: JCO Precis Oncol Año: 2022 Tipo del documento: Article País de afiliación: Países Bajos Pais de publicación: Estados Unidos